We describe the case of a patient with hypertrophic cardiomyopathy who experienced the failure of a transvenous implantable cardioverter defibrillator (T-ICD) lead and the following inability of a second T-ICD to convert a ventricular fibrillation. A subcutaneous ICD (S-ICD) was finally implanted and was effective at defibrillation test.
| INTRODUCTION
In hypertrophic cardiomyopathy (HCM) patients, increased myocardial mass may make it difficult to interrupt ventricular arrhythmias by implantable cardioverter defibrillator (ICD). We describe the case of a patient with HCM who experienced the failure of a transvenous ICD (T-ICD) lead and the following inability of a second T-ICD to convert a ventricular fibrillation. A subcutaneous ICD (S-ICD) was finally implanted and was effective at defibrillation test (DFT).
| CASE REPORT
A 20-year-old male patient was admitted to the emergency room of our center after ICD shock delivery. His past medical history In conclusion, the S-ICD proved to be effective in this patient with HCM, previous failure of transvenous ICD lead, and inability of a T-ICD to convert a ventricular fibrillation. Therefore, in young HCM patients who do not require pacing, S-ICD can be considered a first-line therapy for the prevention of sudden cardiac death. Nonetheless, either with transvenous ICD or with S-ICD the defibrillation testing should not be abandoned in this population.
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